주메뉴 바로가기
본문 바로가기
메인으로 이동
For Tomorrow, LigaChemBio
About Us
Message from CEO
Overview
History
VISION 2030
Leadership
R&D
Research Area
Core Technology
Partnerships
Pipeline
ADC
Small molecule
Investors
Stock
Disclosure
Corporate Presentations
Analyst Coverage
Press Release
Notice
Financial Information
ESG
ESG Overview
Environment
Social
Governance
ESG Dataroom
Careers
Our Culture
Process
Current Job Opportunities
Language
Korean
English
Menu
Investors
home
:
Investors
:
Disclosure
Disclosure
Disclosure chart
As of 2026-04-21 19:34:15
Information provided: KOSCOM DATA
Material Management Information related to Judgment of Investment(Application for IND Approval)(CLDN18.2 항체-약물 접합체 (ADC) LCB02A의 제 1/2상 임상시험의 미국 임상시험계획(IND) 승인 신청)
2026-04-14
Material Management Information related to Judgment of Investment(신규 기전 신약 연구개발을 위한 기술도입 계약 체결)
2026-04-06
Material Management Information related to Judgment of Investment(신규 항체-약물 결합체(ADC) 연구개발을 위한 공동연구 및 항체 기술도입 계약 해지)
2026-04-02
Outcomes of Annual Meeting of Shareholders
2026-03-31
Organization of Investor Relations Event
2026-03-25
Submission of Audit Report
2026-03-23
Resolutions for Convocation of General Meeting of Shareholders
2026-03-10
Material Management Information related to Judgment of Investment(신규 항체약물 결합체(ADC) 연구개발을 위한 항체 기술도입 계약 체결 )
2026-02-24
view more